An update on the lipid nephrotoxicity hypothesis (Q37622061)

21 August 2017

1 reference

title

An update on the lipid nephrotoxicity hypothesis (English)

1 reference

21 August 2017

Xiong Z Ruan

1

1 reference

21 August 2017

Zac Varghese

series ordinal

2

1 reference

21 August 2017

John F Moorhead

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

27 October 2009

1 reference

Nature Reviews Nephrology

21 August 2017

1 reference

21 August 2017

5

1 reference

21 August 2017

12

1 reference

21 August 2017

713-721

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2009.184

21 August 2017

0 references

cites work

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Metabolic origins and clinical significance of LDL heterogeneity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Reducing lipids for CV protection in CKD patients-current evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Lipid abnormalities in uremia, dialysis, and transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Aortic and renal lesions in hypercholesterolemic adult, male, virgin sprague-dawley rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Renal injury of diet-induced hypercholesterolemia in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Serum and tissue lipids and glomerulonephritis in the spontaneously hypercholesterolemic (SHC) rat, with a note on the effects of gonadectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Arterial hypertension and hyperlipidemia as determinants of glomerulosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Inflammation modifies lipid-mediated renal injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Blood pressure related separately to parenchymal fibrosis and vasculopathy of the kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Serum cholesterol falls spontaneously in nephrotic patients with progressive renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Hypertriglyceridemia: an independent risk factor of chronic kidney disease in Taiwanese adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Strategies to improve long-term outcomes after renal transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Hyperlipidemia in solid organ transplantation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Long-term follow-up of a paediatric case of lipoprotein glomerulopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Reactive oxygen species generation in peripheral blood monocytes and oxidized LDL are increased in hyperlipidemic patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Increased oxygen radical and eicosanoid formation in immune-mediated mesangial cell injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Molecular mechanisms of hypertension: role of Nox family NADPH oxidases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Angiotensin II as a cardiovascular risk factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Human mesangial cells express inducible macrophage scavenger receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Oxidation of low-density lipoproteins by rat mesangial cells and the interaction of oxidized low-density lipoproteins with rat mesangial cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Evidence for the presence of 7-hydroperoxycholest-5-en-3 beta-ol in oxidized human LDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Presence of hypochlorite-modified proteins in human atherosclerotic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

The role of obesity and its bioclinical correlates in the progression of chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Oxidized LDL, glomerular mesangial cells and collagen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Signal integration in the endoplasmic reticulum unfolded protein response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Consequences of cellular cholesterol accumulation: basic concepts and physiological implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Glucose amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic beta-cells via activation of mTORC1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Peroxisome deficiency causes a complex phenotype because of hepatic SREBP/Insig dysregulation associated with endoplasmic reticulum stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Transcription factor-kappa B (NF-kappa B) and renal disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Effect of lipoproteins on mesangial cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Effect of interleukin-6 receptor blockage on renal injury in apolipoprotein E-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Inflammation and vascular calcification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Vascular calcification in uremia: what is new and where are we going?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Dyslipidemia and the progression of renal disease in chronic renal failure patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Inflammatory cytokines disrupt LDL-receptor feedback regulation and cause statin resistance: a comparative study in human hepatic cells and mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Reverse cholesterol transport pathway in experimental chronic renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Fat redistribution and adipocyte transformation in uninephrectomized rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Rosuvastatin-induced arrest in progression of renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Effect of pravastatin in people with diabetes and chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Effect of lipid reduction on the progression of renal disease: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Statins for improving renal outcomes: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Effect of pravastatin on proteinuria in patients with well-controlled hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Cardiovascular disease in patients with renal disease: the role of statins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Mechanisms of NADPH oxidase activation in human neutrophils: p67phox is required for the translocation of rac 1 but not of rac 2 from cytosol to the membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Endothelium-dependent effects of statins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Expression of scavenger receptor CD36 in chronic renal failure patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Modulation of inflammatory mediators and PPARgamma and NFkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: a potential mechanism of statin-mediated vasculoprotection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.184

Renal apolipoproteins in nephrotic rats

31 March 2020

1 reference

12 December 2020

Familial LCAT deficiency and fish-eye disease

1 reference

12 December 2020

Allopurinol, an inhibitor of uric acid synthesis--can it be used for the treatment of metabolic syndrome and related disorders?

1 reference

12 December 2020

Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond

1 reference

12 December 2020

Intraglomerular lipid deposition in routine biopsies

1 reference

12 December 2020

Pathologic findings and laboratory data in a new strain of obese hypertensive rats

1 reference

12 December 2020

Transforming growth factor-beta expression in macrophages during hypercholesterolemic states

1 reference

12 December 2020

Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat

1 reference

12 December 2020

Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine

1 reference

12 December 2020

Cholesterol and the risk of renal dysfunction in apparently healthy men.

1 reference

12 December 2020

Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.

1 reference

12 December 2020

Causal link between oxidative stress, inflammation, and hypertension.

1 reference

12 December 2020

The role of altered lipid metabolism in the progression of renal disease: experimental evidence

1 reference

12 December 2020

Effects of genetic obesity on renal structure and function in the Zucker rat

1 reference

12 December 2020

Dietary induced glomerulosclerosis in the guinea pig.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2009.184

1 reference

21 August 2017

1 reference